Alloimmunisation during pregnancy in Greece: Need for nationwide HDFN prevention programme

Transfusion Medicine

Volumn 23, Issue 4, 2013, Pages 254-259

  Foudoulaki Paparizos, L ^a   Valsami, S ^a   Bournas, N ^b   Tsantes, A ^b   Grapsas, P ^c   Mantzios, G ^b   Travlou, A ^b   Politou, M ^b  

^a General Hospital of Nikea   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

Author keywords

Anti D; Maternal alloimmunisation; Pregnancy

Indexed keywords

ALLOANTIBODY; ANTIBODY; BLOOD GROUP M ANTIBODY; CE ANTIBODY; JKA ANTIBODY; JKB ANTIBODY; LEA ANTIBODY; RHESUS C ANTIBODY; RHESUS E ANTIBODY; UNCLASSIFIED DRUG; BLOOD GROUP RHESUS SYSTEM; RHO(D) ANTIGEN;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD GROUP KELL SYSTEM; BLOOD TRANSFUSION; ERYTHROCYTE; FEMALE; FIRST TRIMESTER PREGNANCY; GREECE; HUMAN; IMMIGRANT; IMMUNOASSAY; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PARITY; PREGNANT WOMAN; PRIMIPARA; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; BLOOD; BLOOD GROUP RHESUS SYSTEM; CLINICAL TRIAL; FETOMATERNAL TRANSFUSION; INCIDENCE; MIGRANT; MULTICENTER STUDY; PRACTICE GUIDELINE; PREGNANCY; TERTIARY CARE CENTER;

EMIGRANTS AND IMMIGRANTS; FEMALE; FETOMATERNAL TRANSFUSION; GREECE; HUMANS; INCIDENCE; ISOANTIBODIES; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; RH-HR BLOOD-GROUP SYSTEM; TERTIARY CARE CENTERS;

EID: 84880616484     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12063     Document Type: Article

References (23)

1. Adeniji, A.A., Fuller, I., Dale, T. & Lindow, S.W. (2007) Should we continue screening rhesus D positive women for the development of atypical antibodies in late pregnancy? The Journal of Maternal-Fetal & Neonatal Medicine, 20, 59-61.
2. Dajak, S., Stefanović, V. & Čapkun, V. (2011) Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME). Transfusion, 51, 1380-1388.
3. Davies, J., Chant, R., Simpson, S. & Powell, R. (2011) Routine antenatal anti-D prophylaxis-is the protection adequate? Transfusion Medicine, 21, 421-426.
4. De Young-Owens, A., Kennedy, M., Rose, R.L., Boyle, J. & O'Shaughnessy, R. (1997) Anti-M isoimmunization: management and outcome at the Ohio State University from 1969 to 1995. Obstetrics and Gynecology, 90, 962-966.
5. Engelfriet, C.P., Reesink, H.W., Judd, W.J. et al. (2003) Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sanguinis, 85, 328-337.
6. European Union Agency for Fundamental Rights (FRA) (2011) Migrants in an irregular situation: access to healthcare in 10 European Union Member States (ed Union, L.P.O.o.t.E.), Luxembourg.
7. Filbey, D., Hanson, U. & Wesström, G. (1995) The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn. Acta Obstetricia et Gynecologica Scandinavica, 74, 687-692.
8. Giblett, E. (1964) Blood group antibodies causing hemolytic disease of the newborn. Clinical Obstetrics and Gynecology, 7, 1044-1055.
9. Gottvall, T. & Filbey, D. (2008) Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden. Acta Obstetricia et Gynecologica Scandinavica, 87, 843-848.
10. Harrison, J. (1970) The 'naturally occurring' anti-E. Vox Sanguinis, 19, 123-131.
11. Heddle, N.M., Klama, L., Frassetto, R., O'Hoski, P. & Leaman, B. (1993) A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion, 33, 217-220.
12. Joy, S.D., Rossi, K.Q., Krugh, D. & O'Shaughnessy, R.W. (2005) Management of pregnancies complicated by anti-E alloimmunization. Obstetrics and Gynecology, 105, 24-28.
13. Judd, W.J. (2011) When should tests for unexpected antibodies be done during pregnancy? Transfusion, 51, 1366-1368.
14. Klein, H.G. & Anstee, D.J. (2005) In: Mollison's Blood Transfusion in Clinical Medicine (ed). Blackwell Publishing Ltd, Oxford.
15. Koelewijn, J.M., Vrijkotte, T.G., van der, Schoot, C.E., Bonsel, G.J. & de, Haas, M. (2008) Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion, 48, 941-952.
16. Koelewijn, J.M., Vrijkotte, T.G., de, Haas, M., van der, Schoot, C.E. & Bonsel, G.J. (2009) Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy. BJOG: An International Journal of Obstetrics and Gynaecology, 116, 655-664.
17. Lee, C.K., Ma, E.S.K., Tang, M., Lam, C.C.K., Lin, C.K. & Chan, L.C. (2003) Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy-a review of cases from 1997 to 2001. Transfusion Medicine, 13, 227-231.
18. Malde, R., Stanworth, S., Patel, S. & Knight, R. (2000) Haemolytic disease of the newborn due to anti-Ce. Transfusion Medicine, 10, 305-306.
19. Moise, K.J. (2008) Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Seminars in Fetal & Neonatal Medicine, 13, 207-214.
20. Natukunda, B., Mugyenyi, G., Brand, A. & Schonewille, H. (2011) Maternal red blood cell alloimmunisation in South Western Uganda. Transfusion Medicine, 21, 262-266.
21. (NICE) UK National Institute for Health and Clinical Excellence (2008). Routine antenatal anti-D prophylaxis for women who are rhesus D negative Review of NICE technology appraisal guidance 41, NICE technology appraisal guidance 156. National Institute for Health and Clinical Excellence. http://www.nice.org.uk/nicemedia/pdf/TA156Guidance.pdf
22. Ranasinghe, E., Goodyear, E. & Burgess, G. (2003) Anti-Ce complicating two consecutive pregnancies with increasing severity of haemolytic disease of the newborn. Transfusion Medicine, 13, 53-55.
23. Rothenberg, J.M., Weirermiller, B., Dirig, K., Hurd, W.W., Schilder, J. & Golichowski, A. (1999) Is a third-trimester antibody screen in Rh+ women necessary? The American Journal of Managed Care, 5, 1145-1150.